Surprise! Owing to its rhenium(V) center, which bears two terminal oxo ligands, [ReI(O)2(PPh3)2] appears at first glance to be an oxygen-transfer reagent. The complex is, however, a novel catalyst for a reduction: the hydrosilylation of aldehydes and ketones (see scheme).
No takes yet. Share an insight, caveat, or question.
Werner R. Thiel (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: